DXCM
DexCom Inc
NASDAQ: DXCM · HEALTHCARE · MEDICAL DEVICES
$57.56
-2.97% today
Updated 2026-04-29
Market cap
$22.21B
P/E ratio
27.54
P/S ratio
4.76x
EPS (TTM)
$2.09
Dividend yield
—
52W range
$54 – $90
Volume
4.1M
DexCom Inc (DXCM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
17.90%
Operating margin
25.60%
ROE
34.50%
ROA
8.89%
Debt/equity
0.51x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.17M | $-46.60M | -405.07% | -2,273.03% | -2,147.64% |
| 2007 | $4.63M | $-45.88M | -175.25% | -1,008.77% | -991.53% |
| 2008 | $9.84M | $-55.18M | -56.20% | -536.97% | -560.93% |
| 2009 | $29.69M | $-53.52M | 12.33% | -154.36% | -180.26% |
| 2010 | $48.63M | $-55.17M | 37.92% | -93.13% | -113.45% |
| 2011 | $76.27M | $-44.75M | 47.00% | -58.80% | -58.67% |
| 2012 | $99.90M | $-54.50M | 46.65% | -55.76% | -54.55% |
| 2013 | $160.00M | $-29.80M | 62.56% | -18.06% | -18.63% |
| 2014 | $259.20M | $-22.40M | 68.02% | -8.29% | -8.64% |
| 2015 | $402.00M | $-57.60M | 69.25% | -14.20% | -14.33% |
| 2016 | $573.30M | $-65.60M | 66.00% | -11.15% | -11.44% |
| 2017 | $718.50M | $-50.20M | 68.49% | -5.92% | -6.99% |
| 2018 | $1.03B | $-127.10M | 64.36% | -18.06% | -12.32% |
| 2019 | $1.48B | $101.10M | 63.11% | 9.64% | 6.85% |
| 2020 | $1.93B | $493.60M | 66.44% | 15.54% | 25.62% |
| 2021 | $2.45B | $216.90M | 68.63% | 10.86% | 8.86% |
| 2022 | $2.91B | $341.20M | 64.72% | 13.44% | 11.73% |
| 2023 | $3.62B | $541.50M | 63.19% | 16.50% | 14.95% |
| 2024 | $4.03B | $576.20M | 60.46% | 14.88% | 14.29% |
| 2025 | $4.66B | $836.30M | 60.10% | 19.56% | 17.94% |